Global Adipose Tissue-derived Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 114
Published Date: 07 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.
According to our (Global Info Research) latest study, the global Adipose Tissue-derived Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Adipose Tissue-derived Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adipose Tissue-derived Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Adipose Tissue-derived Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Adipose Tissue-derived Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Adipose Tissue-derived Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adipose Tissue-derived Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adipose Tissue-derived Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AlloCure, Antria, Celgene Corporation, Cellleris and Corestem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Adipose Tissue-derived Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Autologous Stem Cells
Allogeneic Stem Cells
Market segment by Application
Therapeutic Application
Research Application
Market segment by players, this report covers
AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Pluristem Therapeutics
Cyagen
Lonza
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Adipose Tissue-derived Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Adipose Tissue-derived Stem Cell Therapy, with revenue, gross margin and global market share of Adipose Tissue-derived Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Adipose Tissue-derived Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Adipose Tissue-derived Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Adipose Tissue-derived Stem Cell Therapy.
Chapter 13, to describe Adipose Tissue-derived Stem Cell Therapy research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Adipose Tissue-derived Stem Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Adipose Tissue-derived Stem Cell Therapy by Type
1.3.1 Overview: Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type in 2022
1.3.3 Autologous Stem Cells
1.3.4 Allogeneic Stem Cells
1.4 Global Adipose Tissue-derived Stem Cell Therapy Market by Application
1.4.1 Overview: Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Therapeutic Application
1.4.3 Research Application
1.5 Global Adipose Tissue-derived Stem Cell Therapy Market Size & Forecast
1.6 Global Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast by Region
1.6.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region, (2018-2029)
1.6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2018-2029)
2.1 AlloCure
2.1.1 AlloCure Details
2.1.2 AlloCure Major Business
2.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.1.4 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AlloCure Recent Developments and Future Plans
2.2 Antria
2.2.1 Antria Details
2.2.2 Antria Major Business
2.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.2.4 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Antria Recent Developments and Future Plans
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business
2.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Celgene Corporation Recent Developments and Future Plans
2.4 Cellleris
2.4.1 Cellleris Details
2.4.2 Cellleris Major Business
2.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.4.4 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cellleris Recent Developments and Future Plans
2.5 Corestem
2.5.1 Corestem Details
2.5.2 Corestem Major Business
2.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.5.4 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Corestem Recent Developments and Future Plans
2.6 Cytori Therapeutics
2.6.1 Cytori Therapeutics Details
2.6.2 Cytori Therapeutics Major Business
2.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.6.4 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cytori Therapeutics Recent Developments and Future Plans
2.7 Intrexon
2.7.1 Intrexon Details
2.7.2 Intrexon Major Business
2.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.7.4 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Intrexon Recent Developments and Future Plans
2.8 Mesoblast
2.8.1 Mesoblast Details
2.8.2 Mesoblast Major Business
2.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.8.4 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mesoblast Recent Developments and Future Plans
2.9 Pluristem Therapeutics
2.9.1 Pluristem Therapeutics Details
2.9.2 Pluristem Therapeutics Major Business
2.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.9.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pluristem Therapeutics Recent Developments and Future Plans
2.10 Tissue Genesis
2.10.1 Tissue Genesis Details
2.10.2 Tissue Genesis Major Business
2.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.10.4 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tissue Genesis Recent Developments and Future Plans
2.11 BioRestorative Therapies
2.11.1 BioRestorative Therapies Details
2.11.2 BioRestorative Therapies Major Business
2.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.11.4 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioRestorative Therapies Recent Developments and Future Plans
2.12 Celltex Therapeutics Corporation
2.12.1 Celltex Therapeutics Corporation Details
2.12.2 Celltex Therapeutics Corporation Major Business
2.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.12.4 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Celltex Therapeutics Corporation Recent Developments and Future Plans
2.13 iXCells Biotechnologies
2.13.1 iXCells Biotechnologies Details
2.13.2 iXCells Biotechnologies Major Business
2.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.13.4 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 iXCells Biotechnologies Recent Developments and Future Plans
2.14 Pluristem Therapeutics
2.14.1 Pluristem Therapeutics Details
2.14.2 Pluristem Therapeutics Major Business
2.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.14.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Pluristem Therapeutics Recent Developments and Future Plans
2.15 Cyagen
2.15.1 Cyagen Details
2.15.2 Cyagen Major Business
2.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.15.4 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Cyagen Recent Developments and Future Plans
2.16 Lonza
2.16.1 Lonza Details
2.16.2 Lonza Major Business
2.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Product and Solutions
2.16.4 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Lonza Recent Developments and Future Plans
3.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Adipose Tissue-derived Stem Cell Therapy by Company Revenue
3.2.2 Top 3 Adipose Tissue-derived Stem Cell Therapy Players Market Share in 2022
3.2.3 Top 6 Adipose Tissue-derived Stem Cell Therapy Players Market Share in 2022
3.3 Adipose Tissue-derived Stem Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Adipose Tissue-derived Stem Cell Therapy Market: Region Footprint
3.3.2 Adipose Tissue-derived Stem Cell Therapy Market: Company Product Type Footprint
3.3.3 Adipose Tissue-derived Stem Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Adipose Tissue-derived Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Type (2024-2029)
5.1 Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Application (2024-2029)
6.1 North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2029)
6.2 North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2029)
6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country
6.3.1 North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
7.1 Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2029)
7.2 Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2029)
7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country
7.3.1 Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.3 France Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
8.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2018-2029)
8.3.2 China Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.5 India Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
9.1 South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2029)
9.2 South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2029)
9.3 South America Adipose Tissue-derived Stem Cell Therapy Market Size by Country
9.3.1 South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
10.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2018-2029)
11.1 Adipose Tissue-derived Stem Cell Therapy Market Drivers
11.2 Adipose Tissue-derived Stem Cell Therapy Market Restraints
11.3 Adipose Tissue-derived Stem Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 Adipose Tissue-derived Stem Cell Therapy Industry Chain
12.2 Adipose Tissue-derived Stem Cell Therapy Upstream Analysis
12.3 Adipose Tissue-derived Stem Cell Therapy Midstream Analysis
12.4 Adipose Tissue-derived Stem Cell Therapy Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AlloCure Company Information, Head Office, and Major Competitors
Table 6. AlloCure Major Business
Table 7. AlloCure Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 8. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AlloCure Recent Developments and Future Plans
Table 10. Antria Company Information, Head Office, and Major Competitors
Table 11. Antria Major Business
Table 12. Antria Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 13. Antria Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Antria Recent Developments and Future Plans
Table 15. Celgene Corporation Company Information, Head Office, and Major Competitors
Table 16. Celgene Corporation Major Business
Table 17. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 18. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Celgene Corporation Recent Developments and Future Plans
Table 20. Cellleris Company Information, Head Office, and Major Competitors
Table 21. Cellleris Major Business
Table 22. Cellleris Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 23. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cellleris Recent Developments and Future Plans
Table 25. Corestem Company Information, Head Office, and Major Competitors
Table 26. Corestem Major Business
Table 27. Corestem Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 28. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Corestem Recent Developments and Future Plans
Table 30. Cytori Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Cytori Therapeutics Major Business
Table 32. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 33. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cytori Therapeutics Recent Developments and Future Plans
Table 35. Intrexon Company Information, Head Office, and Major Competitors
Table 36. Intrexon Major Business
Table 37. Intrexon Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 38. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Intrexon Recent Developments and Future Plans
Table 40. Mesoblast Company Information, Head Office, and Major Competitors
Table 41. Mesoblast Major Business
Table 42. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 43. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Mesoblast Recent Developments and Future Plans
Table 45. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Pluristem Therapeutics Major Business
Table 47. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 48. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pluristem Therapeutics Recent Developments and Future Plans
Table 50. Tissue Genesis Company Information, Head Office, and Major Competitors
Table 51. Tissue Genesis Major Business
Table 52. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 53. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Tissue Genesis Recent Developments and Future Plans
Table 55. BioRestorative Therapies Company Information, Head Office, and Major Competitors
Table 56. BioRestorative Therapies Major Business
Table 57. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 58. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BioRestorative Therapies Recent Developments and Future Plans
Table 60. Celltex Therapeutics Corporation Company Information, Head Office, and Major Competitors
Table 61. Celltex Therapeutics Corporation Major Business
Table 62. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 63. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Celltex Therapeutics Corporation Recent Developments and Future Plans
Table 65. iXCells Biotechnologies Company Information, Head Office, and Major Competitors
Table 66. iXCells Biotechnologies Major Business
Table 67. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 68. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. iXCells Biotechnologies Recent Developments and Future Plans
Table 70. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Pluristem Therapeutics Major Business
Table 72. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 73. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Pluristem Therapeutics Recent Developments and Future Plans
Table 75. Cyagen Company Information, Head Office, and Major Competitors
Table 76. Cyagen Major Business
Table 77. Cyagen Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 78. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Cyagen Recent Developments and Future Plans
Table 80. Lonza Company Information, Head Office, and Major Competitors
Table 81. Lonza Major Business
Table 82. Lonza Adipose Tissue-derived Stem Cell Therapy Product and Solutions
Table 83. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Lonza Recent Developments and Future Plans
Table 85. Global Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
Table 86. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Players (2018-2023)
Table 87. Breakdown of Adipose Tissue-derived Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Adipose Tissue-derived Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Adipose Tissue-derived Stem Cell Therapy Players
Table 90. Adipose Tissue-derived Stem Cell Therapy Market: Company Product Type Footprint
Table 91. Adipose Tissue-derived Stem Cell Therapy Market: Company Product Application Footprint
Table 92. Adipose Tissue-derived Stem Cell Therapy New Market Entrants and Barriers to Market Entry
Table 93. Adipose Tissue-derived Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Table 96. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
Table 97. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2023)
Table 98. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
Table 99. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Adipose Tissue-derived Stem Cell Therapy Raw Material
Table 130. Key Suppliers of Adipose Tissue-derived Stem Cell Therapy Raw Materials
List of Figures
Figure 1. Adipose Tissue-derived Stem Cell Therapy Picture
Figure 2. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. Autologous Stem Cells
Figure 5. Allogeneic Stem Cells
Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application in 2022
Figure 8. Therapeutic Application Picture
Figure 9. Research Application Picture
Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Adipose Tissue-derived Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Region in 2022
Figure 15. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Players in 2022
Figure 21. Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Adipose Tissue-derived Stem Cell Therapy Market Share in 2022
Figure 23. Global Top 6 Players Adipose Tissue-derived Stem Cell Therapy Market Share in 2022
Figure 24. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Figure 25. Global Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Type (2024-2029)
Figure 26. Global Adipose Tissue-derived Stem Cell Therapy Consumption Value Share by Application (2018-2023)
Figure 27. Global Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Application (2024-2029)
Figure 28. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. France Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 45. China Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. India Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Adipose Tissue-derived Stem Cell Therapy Market Drivers
Figure 63. Adipose Tissue-derived Stem Cell Therapy Market Restraints
Figure 64. Adipose Tissue-derived Stem Cell Therapy Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Adipose Tissue-derived Stem Cell Therapy in 2022
Figure 67. Manufacturing Process Analysis of Adipose Tissue-derived Stem Cell Therapy
Figure 68. Adipose Tissue-derived Stem Cell Therapy Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AlloCure Antria Celgene Corporation Cellleris Corestem Cytori Therapeutics Intrexon Mesoblast Pluristem Therapeutics Tissue Genesis BioRestorative Therapies Celltex Therapeutics Corporation iXCells Biotechnologies Pluristem Therapeutics Cyagen Lonza
Related Reports
19 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
